Industry News
Latest orthopaedic industry news on orthopaedic companies, devices, implants & technology trends.
- Written by Editor-in-Chief
- Category: Industry News
The report “Global Hearing Aid Market” provides an in-depth analysis of the global market along with markets of the US and Europe. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The industry comprises few large players such as Sonova, William Demant and GN Re Sound. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth. Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=504970. Hearing aid market is an emerging healthcare market due to introduction of various innovations and dynamics.
- Written by Editor-in-Chief
- Category: Industry News
I can't but agree to the positive statements about your portal: easy to use, clear layout, very good search function, and quick editing! Jens O'Brien, Borgmeier Media Communication
- Written by Editor-in-Chief
- Category: Industry News
Details from the Promimic announcement follow: Magnus Larsson has a solid background in Sales and Marketing, having held a number of leadership positions in the international dental implant industry over the last 15 years. Most recently he was Director, Global Market Development, at Dentsply Sirona Implants, Mölndal, Sweden. Former CEO Ulf Brogren is relocating to the US to launch Promimic Inc.’s new North American sales operations in Austin, Texas. This new commercial operation is aimed bringing Promimic closer to the market and to its customer base in North America, the largest market for orthopedic and dental implants.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are five things to know: 1. The University of New Mexico Hospital is the state's sole Level 1 trauma center. 2. Jeremy Lewis, MD, an assistant neurosurgery professor, will serve as principal investigator. 3. Dr. Lewis completed his complex cranial and skull base surgery fellowship at University of Texas Southwestern in Dallas. 4. The University of New Mexico Hospital joins 29 other clinical sites participating in the INSPIRE study. 5. The INSPIRE study tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.
- Written by Editor-in-Chief
- Category: Industry News
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials. Following types of plate rich plasma (PRP) preparations are currently available in the market:Leukocyte-poor or pure PRPLeukocyte PRPPure platelet-rich fibrin clotLeukocyte platelet-rich fibrin clotFree Sample Report@ http://www.sa-brc.com/Global-Platelet-Rich-Plasma-PRP-Market-Assessment–Forecast-2016-2020/up54 In spite of non-regulatory approval, PRP has been widely used in sports medicine.
- Written by Editor-in-Chief
- Category: Industry News
President Barack Obama’s $1 billion commitment to make American manufacturing more competitive took another step forward Friday when Carnegie Mellon University and the U.S. Department of Defense announced plans for a $253 million robotics research initiative based in Pittsburgh. The center — funded by 220 government, industry and academic sources — is the latest of 14 manufacturing institutes that are researching technologies like 3-D printing medical implants that will help broken bones heal faster; working on new, streamlined ways of manufacturing lightweight metals; and developing breakthrough fabrics capable of storing energy and monitoring the health of the person who wears them.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are four things to know: 1. This patent application covers Aurora's implant family of ZIP ISPs as well as its first polyaxial implant design. 2. The company's new polyaxial interspinous devices offers "full polyaxial maneuverability of the implant components in difficult situations during minimally invasive fusion cases," said Laszlo Garamszegi, Aurora Spine's chief technology officer. 3. This patent represents Aurora Spine's second allowed U.S. patent. 4. The company also has other pending U.S. and international patent applications.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are five notes: 1. The FDA cleared the G-Arm B6 Duo, which is a next-generation G-Arm featuring axial tilt and enhanced table access. 2. The surgical imaging technology is intended for orthopedic, spine and neurosurgeons as well as pain physicians. 3. The G-Arm B6 Duo is designed to boost accuracy as well as cut time, infection and radiation. 4. The technology utilizes two X-ray beans asynchronously, offering bilateral video and images. 5. The G-Arm features X-Beam technology and iC-Clear algorithms.
- Written by Editor-in-Chief
- Category: Industry News
Johnson & Johnson Medical Devices Companies recently announced the launch of CareAdvantage, its answer to the value-based care environment. A top JNJ executive explains why he thinks the company’s offering has an edge. Marie Thibault Johnson & Johnson Medical Devices Companies (JJMDC) is jumping feet first into the value-based care environment with its new CareAdvantage offering. The broad program, announced on January 9, aims to help hospital customers achieve the ultimate goal of value-based care: improving outcomes, increasing patient satisfaction, and reducing the cost of care. According to a company press release announcing the launch, CareAdvantage is designed to offer customers insights in a wide variety of therapy areas, interpretation of patient behaviors in order to improve patient outcomes and satisfaction, and optimization of operations in order to reduce care costs.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are four key notes: 1. The agreement includes DenerveX System distribution in Italy. 2. Via the agreement, AlfaMed will provide sales, marketing and distribution services for the DenerveX System launch. 3. The DenerveX System includes the DenerveX device and the DenerveX Pro-40 Power Generator. The system is intended to relieve pain associated with the facet joint. 4. Currently, the DenerveX is not FDA cleared or CE marked. More articles on devices: How consolidation, bundled payments and standardization shape the medical device field: Key thoughts from Johnson & Johnson Medical Devices Companies' Tim Schmid
Submit Community Content
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!